Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness

BACKGROUND & AIMS: Hepatitis C virus (HCV) eradication with direct-acting antivirals (DAAs) reduces but does not eliminate the risk for hepatocellular carcinoma (HCC). The development of surveillance strategies for HCC after the sustained virologic response (SVR) is therefore warranted. We aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Dajti, Elton, Marasco, Giovanni, Ravaioli, Federico, Colecchia, Luigi, Ferrarese, Alberto, Festi, Davide, Colecchia, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165428/
https://www.ncbi.nlm.nih.gov/pubmed/34095798
http://dx.doi.org/10.1016/j.jhepr.2021.100289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165428/
https://www.ncbi.nlm.nih.gov/pubmed/34095798
http://dx.doi.org/10.1016/j.jhepr.2021.100289

Ejemplares similares